• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二甲双胍可减轻环孢素 A 诱导的大鼠肾纤维化。

Metformin Attenuates Cyclosporine A-induced Renal Fibrosis in Rats.

机构信息

Research Center of Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

Department of Cardiothoracic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.

出版信息

Transplantation. 2019 Oct;103(10):e285-e296. doi: 10.1097/TP.0000000000002864.

DOI:10.1097/TP.0000000000002864
PMID:31335763
Abstract

BACKGROUND

The aim of the present study was to investigate the therapeutic potential of metformin in preventing cyclosporine A (CsA)-induced nephrotoxicity.

METHODS

Three groups of adult male Sprague-Dawley rats were treated with vehicle, CsA, and CsA + metformin for 4 weeks following 1 week on low sodium diet, respectively. At the end of treatment, all animals were euthanized, and the samples of kidney, urine, and blood were collected for functional, morphological, and molecular biological evaluation.

RESULTS

Metformin effectively prevented CsA-induced renal dysfunction with increased creatinine clearance rate and reduced blood urea nitrogen and serum creatinine, as well as less proteinuria in comparison to the CsA group. Morphologically, metformin ameliorated CsA-induced renal fibrosis and tissue collapse in the areas of arteries, glomeruli, and proximal tubules. We further demonstrated that the antifibrotic effects of metformin in kidneys treated with CsA were associated with decreased phosphorylation of extracellular signal-regulated kinase1/2 (ERK1/2).

CONCLUSIONS

In conclusion, our study revealed new therapeutic potential of metformin to attenuate calcineurin inhibitor-induced renal fibrosis, which was closely related to the suppression of MEK/ERK1/2 pathway.

摘要

背景

本研究旨在探讨二甲双胍在预防环孢素 A(CsA)诱导的肾毒性中的治疗潜力。

方法

成年雄性 Sprague-Dawley 大鼠分为三组,分别给予 vehicle、CsA 和 CsA+二甲双胍治疗 4 周,同时给予低钠饮食 1 周。治疗结束时,所有动物均安乐死,采集肾脏、尿液和血液样本进行功能、形态和分子生物学评估。

结果

与 CsA 组相比,二甲双胍可有效预防 CsA 诱导的肾功能障碍,增加肌酐清除率,降低血尿素氮和血清肌酐,减少蛋白尿。形态学上,二甲双胍改善了 CsA 诱导的肾纤维化和动脉、肾小球和近端小管区域的组织塌陷。我们进一步表明,在 CsA 处理的肾脏中,二甲双胍的抗纤维化作用与细胞外信号调节激酶 1/2(ERK1/2)磷酸化的减少有关。

结论

总之,我们的研究揭示了二甲双胍减轻钙调神经磷酸酶抑制剂诱导的肾纤维化的新治疗潜力,这与 MEK/ERK1/2 通路的抑制密切相关。

相似文献

1
Metformin Attenuates Cyclosporine A-induced Renal Fibrosis in Rats.二甲双胍可减轻环孢素 A 诱导的大鼠肾纤维化。
Transplantation. 2019 Oct;103(10):e285-e296. doi: 10.1097/TP.0000000000002864.
2
Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: attenuation by trimetazidine.环孢素A介导的大鼠氧化应激性肾功能障碍:曲美他嗪的减轻作用
Ren Fail. 2002 May;24(3):259-74. doi: 10.1081/jdi-120005360.
3
Urotensin receptor antagonist palosuran attenuates cyclosporine-a-induced nephrotoxicity in rats.尿皮质素受体拮抗剂 palosuran 可减轻大鼠环孢素 A 诱导的肾毒性。
Adv Clin Exp Med. 2019 Oct;28(10):1393-1401. doi: 10.17219/acem/104544.
4
Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity.选择性血管紧张素II 1型受体阻断可改善环孢素肾毒性。
Pharmacol Res. 2002 May;45(5):413-20. doi: 10.1006/phrs.2002.0959.
5
Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.依普利酮对局部醛固酮的抑制作用可减轻新型慢性环孢素A肾毒性模型中的肾脏结构损伤。
J Renin Angiotensin Aldosterone Syst. 2015 Jun;16(2):301-10. doi: 10.1177/1470320314561248. Epub 2014 Dec 10.
6
Rosuvastatin attenuates inflammation, apoptosis and fibrosis in a rat model of cyclosporine-induced nephropathy.罗苏伐他汀减轻环孢素诱导的肾病大鼠模型中的炎症、细胞凋亡和纤维化。
Am J Nephrol. 2013;37(1):7-15. doi: 10.1159/000345990. Epub 2012 Dec 21.
7
Attenuation of cyclosporine-induced renal dysfunction by catechin: possible antioxidant mechanism.儿茶素减轻环孢素诱导的肾功能障碍:可能的抗氧化机制。
Ren Fail. 2003 Sep;25(5):691-707. doi: 10.1081/jdi-120024285.
8
Molecular basis of the counteraction by calcium channel blockers of cyclosporine nephrotoxicity.钙通道阻滞剂拮抗环孢素肾毒性的分子基础。
Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F572-F582. doi: 10.1152/ajprenal.00275.2017. Epub 2018 May 16.
9
Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in rats.槲皮素,一种生物类黄酮,可保护大鼠免受环孢素引起的氧化应激相关肾功能障碍的影响。
Methods Find Exp Clin Pharmacol. 2001 May;23(4):175-81. doi: 10.1358/mf.2001.23.4.634641.
10
Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-β1/IL-2/COX-2/endothelin ET(B) receptor cascade.塞来昔布通过调节 TGF-β1/IL-2/COX-2/内皮素 ET(B)受体级联来抵消环孢素的负性肾脏影响。
Toxicol Appl Pharmacol. 2014 Mar 1;275(2):88-95. doi: 10.1016/j.taap.2014.01.008. Epub 2014 Jan 21.

引用本文的文献

1
Understanding and targeting senescence in kidney disease.了解并针对肾脏疾病中的衰老现象
Clin Kidney J. 2025 Jul 7;18(8):sfaf190. doi: 10.1093/ckj/sfaf190. eCollection 2025 Aug.
2
The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study.二甲双胍对使用钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的糖尿病患者肾脏疾病进展和死亡率的影响:一项真实世界队列研究。
Cardiovasc Diabetol. 2025 Feb 28;24(1):97. doi: 10.1186/s12933-025-02643-6.
3
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin.
2型糖尿病患者接受二甲双胍抗糖尿病治疗后尿中性粒细胞明胶酶相关脂质运载蛋白、纤连蛋白和层粘连蛋白排泄量的变化
J Clin Med. 2025 Feb 8;14(4):1088. doi: 10.3390/jcm14041088.
4
From Adipose to Ailing Kidneys: The Role of Lipid Metabolism in Obesity-Related Chronic Kidney Disease.从脂肪到患病肾脏:脂质代谢在肥胖相关慢性肾脏病中的作用
Antioxidants (Basel). 2024 Dec 16;13(12):1540. doi: 10.3390/antiox13121540.
5
Metformin Exhibits Anti-Inflammatory Effects by Regulating microRNA-451/CXCL16 and B Cell Leukemia/Lymphoma 2 in Patients With Osteoarthritis.二甲双胍通过调节骨关节炎患者的微小RNA-451/CXCL16和B细胞淋巴瘤-2发挥抗炎作用。
ACR Open Rheumatol. 2025 Jan;7(1):e11755. doi: 10.1002/acr2.11755. Epub 2024 Oct 22.
6
Delaying Renal Aging: Metformin Holds Promise as a Potential Treatment.延缓肾脏衰老:二甲双胍有望成为一种潜在的治疗方法。
Aging Dis. 2024 Jun 6;16(3):1397-1413. doi: 10.14336/AD.2024.0168.
7
Rationale and Design of a Phase 2, Double-blind, Placebo-Controlled, Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis.一项评估二甲双胍激活AMP激酶治疗局灶节段性肾小球硬化的2期双盲安慰剂对照随机试验的原理与设计
Kidney Int Rep. 2024 Feb 13;9(5):1354-1368. doi: 10.1016/j.ekir.2024.02.006. eCollection 2024 May.
8
Immunolocalization of Matrix Metalloproteinases 2 and 9 and Their Inhibitors in the Hearts of Rats Treated with Immunosuppressive Drugs-An Artificial Intelligence-Based Digital Analysis.免疫抑制药物治疗大鼠心脏中基质金属蛋白酶2和9及其抑制剂的免疫定位——基于人工智能的数字分析
Biomedicines. 2024 Mar 30;12(4):769. doi: 10.3390/biomedicines12040769.
9
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease.慢性肾脏病中的肾脏脂质代谢紊乱和脂滴积累。
Nat Rev Nephrol. 2023 Oct;19(10):629-645. doi: 10.1038/s41581-023-00741-w. Epub 2023 Jul 27.
10
Comparative effectiveness of metformin versus sulfonylureas on kidney function decline or death among patients with reduced kidney function: a retrospective cohort study.比较肾功能减退患者中二甲双胍与磺脲类药物对肾功能下降或死亡的疗效:一项回顾性队列研究。
CMAJ Open. 2023 Jan 31;11(1):E77-E89. doi: 10.9778/cmajo.20210207. Print 2023 Jan-Feb.